Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | -60.54%979K | -60.54%979K | 34.98%2.48M | 34.98%2.48M | 39.45%1.84M | 39.45%1.84M | -11.13%1.32M | -11.13%1.32M | 36.93%1.48M | 36.93%1.48M |
| -Cash and cash equivalents | -60.54%979K | -60.54%979K | 34.98%2.48M | 34.98%2.48M | 39.45%1.84M | 39.45%1.84M | -11.13%1.32M | -11.13%1.32M | 36.93%1.48M | 36.93%1.48M |
| Long term equity investment | 0.70%713.67M | 0.70%713.67M | 25.00%708.69M | 25.00%708.69M | 1.06%566.94M | 1.06%566.94M | 60.17%560.99M | 60.17%560.99M | 1.12%350.24M | 1.12%350.24M |
| Receivables | 53.07%8.04M | 53.07%8.04M | 3.27%5.25M | 3.27%5.25M | 33.37%5.08M | 33.37%5.08M | 13.76%3.81M | 13.76%3.81M | -11.56%3.35M | -11.56%3.35M |
| -Accounts receivable | 39.22%6.64M | 39.22%6.64M | -2.75%4.77M | -2.75%4.77M | 33.78%4.9M | 33.78%4.9M | 12.35%3.67M | 12.35%3.67M | -11.91%3.26M | -11.91%3.26M |
| -Other receivables | 190.04%1.4M | 190.04%1.4M | 166.30%482K | 166.30%482K | 23.13%181K | 23.13%181K | 65.17%147K | 65.17%147K | 3.49%89K | 3.49%89K |
| Total assets | 0.87%722.68M | 0.87%722.68M | 24.84%716.42M | 24.84%716.42M | 1.37%573.86M | 1.37%573.86M | 59.44%566.12M | 59.44%566.12M | 1.09%355.07M | 1.09%355.07M |
| Liabilities | ||||||||||
| Payables | 29.04%9.61M | 29.04%9.61M | -1.09%7.45M | -1.09%7.45M | 19.87%7.53M | 19.87%7.53M | 87.91%6.28M | 87.91%6.28M | -13.06%3.34M | -13.06%3.34M |
| -Accounts payable | 29.43%9.51M | 29.43%9.51M | -1.22%7.35M | -1.22%7.35M | 21.60%7.44M | 21.60%7.44M | 87.09%6.12M | 87.09%6.12M | 678.33%3.27M | 678.33%3.27M |
| -Other payable | 0.00%100K | 0.00%100K | 9.89%100K | 9.89%100K | -44.51%91K | -44.51%91K | 124.66%164K | 124.66%164K | -12.05%73K | -12.05%73K |
| Other liabilities | --1K | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total liabilities | 29.05%9.61M | 29.05%9.61M | -1.09%7.45M | -1.09%7.45M | 19.87%7.53M | 19.87%7.53M | 87.91%6.28M | 87.91%6.28M | -13.06%3.34M | -13.06%3.34M |
| Shareholders'equity | ||||||||||
| Share capital | 0.58%713.07M | 0.58%713.07M | 25.19%708.98M | 25.19%708.98M | 1.16%566.33M | 1.16%566.33M | 59.17%559.84M | 59.17%559.84M | 1.25%351.73M | 1.25%351.73M |
| -common stock | 0.58%713.07M | 0.58%713.07M | 25.19%708.98M | 25.19%708.98M | 1.16%566.33M | 1.16%566.33M | 59.17%559.84M | 59.17%559.84M | 1.25%351.73M | 1.25%351.73M |
| Total stockholders'equity | 0.58%713.07M | 0.58%713.07M | 25.19%708.98M | 25.19%708.98M | 1.16%566.33M | 1.16%566.33M | 59.17%559.84M | 59.17%559.84M | 1.25%351.73M | 1.25%351.73M |
| Total equity | 0.58%713.07M | 0.58%713.07M | 25.19%708.98M | 25.19%708.98M | 1.16%566.33M | 1.16%566.33M | 59.17%559.84M | 59.17%559.84M | 1.25%351.73M | 1.25%351.73M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |